A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes

INTRODUCTION: This 32-week, open-label, randomized, parallel-group, multinational trial aimed to compare the efficacy and safety of stepwise insulin intensification of biphasic insulin aspart 30 (BIAsp 30) relative to stepwise intensification of a basal–bolus regimen in insulin-naïve adults with typ...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes Ther
Main Authors: Linjawi, Sultan, Lee, Byung-Wan, Tabak, Ömür, Lövdahl, Susanna, Werther, Shanti, Abusnana, Salahedeen
Format: Artigo
Language:Inglês
Published: Springer Healthcare 2017
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5801220/
https://ncbi.nlm.nih.gov/pubmed/29129018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-017-0334-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items